Canada — Canadian Intellectual Property Office
Tracked across 2 events · 13 articles · First seen May 29, 2026 · Last active Aug 18, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Silo Pharma announced that the Canada — Canadian Intellectual Property Office (CIPO) issued a Notice of Allowance for a patent application covering SPC-15, its lead intranasal 5-HT4 receptor agonist for PTSD and other stress-induced psychiatric…
Impact: The Canada — Canadian Intellectual Property Office issued the Notice of Allowance, granting patent protection for SPC-15 in Canada. This is a routine regulatory action.
Aug 18, 2026 · 6 articles
Business
Impact: The Canada — Canadian Intellectual Property Office issued Notices of Allowance for two patent applications to Actinium Pharmaceuticals, playing a key role in the expansion of Actinium Pharmaceuticals' intellectual property in Canada.
May 29, 2026 · 7 articles
90
Canada — Canadian Intellectual Property Office issued notice of allowance Silo PharmaSilo Pharma Canadian...
ERGEN INTELLIGENCE
Track Canada — Canadian Intellectual Property Office live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard